1st Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$990,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

No bill, lobbied on patent troll issues regarding biopharmaceutical patents.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

Lobbied regarding intellectual property rights in trade agreements and international negotiations.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Health Issues HCR

No bill, lobbied to raise awareness about Atrial Fibrillation and stroke prevention. H.R. 878, Right to Try Act of 2017 and S. 204, Trickett Wendler Right to Try Act of 2017,lobbied regarding all biopharmaceutical provisions. Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, lobbied regarding all biopharmaceutical provisions. No bill, lobbied regarding biosimilars issues including naming, labeling and interchangeability. FDA Reauthorization Act, lobbied regarding all biopharmaceutical provisions. H.R. 1245 and S. 469, Affordable and Safe Prescription Drug Importation Act, lobbied regarding all biopharmaceutical provisions. H.R.1231 and S. 456, RACE for Children Act, lobbied regarding all biopharmaceutical provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 1231 (115th), S. 204 (115th), H.R. 1245 (115th), S. 469 (115th), H.R. 878 (115th), S. 456 (115th)

Medicare/Medicaid MMM

H.R. 849, S. 260, S. 251 Protecting Seniors Access to Medicare Act, lobbied regarding all biopharmaceutical related provisions. No bill, Children's Health Insurance Program, lobbied regarding all biopharmaceutical related provisions. S.771, Improving Access To Affordable Prescription Drugs Act, lobbied regarding all biopharmaceutical related provisions. S.348, Prescription Drug and Health Improvement Act of 2017, lobbied regarding all biopharmaceutical related provisions. S.637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017, lobbied regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 348 (115th), H.R. 849 (115th), S. 260 (115th), S. 637 (115th), S. 771 (115th), S. 251 (115th)

Budget/Appropriations BUD

American Health Care Act, regarding all biopharmaceutical related provisions. Continuing Budget Resolution, lobbied regarding all biopharmaceutical provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.